Consensus document on the management of febrile neutropenia in paediatric haematology and oncology patients of the Spanish Society of Pediatric Infectious Diseases (SEIP) and the Spanish Society of Pediatric Hematology and Oncology (SEHOP)

Febrile neutropenia is one of the main infectious complications experienced by paediatric patients with blood or solid tumours, which, despite the advances in diagnosis and treatment, are still associated with a significant morbidity and mortality. These patients have several risk factors for infect...

Full description

Bibliographic Details
Main Authors: Leticia Martínez Campos, Paula Pérez-Albert, Laia Ferres Ramis, Elena María Rincón-López, Natalia Mendoza-Palomar, Pere Soler-Palacin, David Aguilera-Alonso
Format: Article
Language:Spanish
Published: Elsevier 2023-06-01
Series:Anales de Pediatría (English Edition)
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2341287923001114
_version_ 1797809831100284928
author Leticia Martínez Campos
Paula Pérez-Albert
Laia Ferres Ramis
Elena María Rincón-López
Natalia Mendoza-Palomar
Pere Soler-Palacin
David Aguilera-Alonso
author_facet Leticia Martínez Campos
Paula Pérez-Albert
Laia Ferres Ramis
Elena María Rincón-López
Natalia Mendoza-Palomar
Pere Soler-Palacin
David Aguilera-Alonso
author_sort Leticia Martínez Campos
collection DOAJ
description Febrile neutropenia is one of the main infectious complications experienced by paediatric patients with blood or solid tumours, which, despite the advances in diagnosis and treatment, are still associated with a significant morbidity and mortality. These patients have several risk factors for infection, chief of which are chemotherapy-induced neutropenia, the disruption of cutaneous and mucosal barriers and the use of intravascular devices. Early diagnosis and treatment of febrile neutropenia episodes based on the patient’s characteristics is essential in patients with blood and solid tumours to improve their outcomes. Therefore, it is important to develop protocols in order to optimise and standardise its management. In addition, the rational use of antibiotics, with careful adjustment of the duration of treatment and antimicrobial spectrum, is crucial to address the increase in antimicrobial drug resistance.The aim of this document, developed jointly by the Spanish Society of Pediatric Infectious Diseases and the Spanish Society of Pediatric Hematology and Oncology, is to provide consensus recommendations for the management of febrile neutropenia in paediatric oncology and haematology patients, including the initial evaluation, the stepwise approach to its treatment, supportive care and invasive fungal infection, which each facility then needs to adapt to the characteristics of its patients and local epidemiological trends. Resumen: La neutropenia febril es una de las principales complicaciones infecciosas que sufren los pacientes pediátricos oncohematológicos, y a pesar los avances en diagnóstico y tratamiento, siguen condicionando una mortalidad y morbilidad significativa. Estos pacientes agrupan una serie de factores de riesgo de infección, donde destaca la neutropenia asociada a quimioterapia, la disrupción de barreras cutáneo-mucosas y el uso de dispositivos intravasculares. El abordaje diagnóstico y terapéutico precoz de los episodios de neutropenia febril en los pacientes oncohematológicos, ajustado a las características individuales de cada paciente, es fundamental para mejorar su pronóstico. Por ello, diseñar protocolos de abordaje, que sistematicen su atención, permite optimizar y homogeneizar su abordaje. Además, racionalizar el uso de los antimicrobianos, ajustando la duración y el espectro de los mismos, es crucial para hacer frente al incremento de resistencias a antimicrobianos.El objetivo de este documento, elaborado entre la Sociedad Española de Infectología Pediátrica y la Sociedad Española de Hematología y Oncología Pediátrica, es dar recomendaciones de consenso sobre el manejo de la neutropenia febril en el paciente oncohematológico, respecto al abordaje inicial, terapia secuencial y de soporte e infección fúngica invasiva, que cada centro debe adaptar a las características de sus pacientes y epidemiología local.
first_indexed 2024-03-13T06:58:44Z
format Article
id doaj.art-2c959a5313c2452484da2a48d9f38bcb
institution Directory Open Access Journal
issn 2341-2879
language Spanish
last_indexed 2024-03-13T06:58:44Z
publishDate 2023-06-01
publisher Elsevier
record_format Article
series Anales de Pediatría (English Edition)
spelling doaj.art-2c959a5313c2452484da2a48d9f38bcb2023-06-07T04:48:30ZspaElsevierAnales de Pediatría (English Edition)2341-28792023-06-01986446459Consensus document on the management of febrile neutropenia in paediatric haematology and oncology patients of the Spanish Society of Pediatric Infectious Diseases (SEIP) and the Spanish Society of Pediatric Hematology and Oncology (SEHOP)Leticia Martínez Campos0Paula Pérez-Albert1Laia Ferres Ramis2Elena María Rincón-López3Natalia Mendoza-Palomar4Pere Soler-Palacin5David Aguilera-Alonso6Unidad de Infectología Pediátrica, Hospital Universitario Torrecárdenas, Almería, SpainServicio de Oncología y Hematología Pediátricas, Hospital Universitari Vall d’Hebron, Barcelona, SpainServicio de Oncohematología Pediátrica, Hospital Universitario Son Espases, Palma, Mallorca, SpainSección Enfermedades Infecciosas Pediátricas, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Área de Enfermedades Infecciosas Pediátricas, Centro de Investigación Biomédica en Red del Instituto de Salud Carlos III (CIBERINFEC), Madrid, SpainUnidad de Patología Infecciosa e Inmunodeficiencias de Pediatría, Hospital Universitari Vall d’Hebron, Barcelona, Spain; Grupo de investigación «Infección e inmunidad en el paciente pediátrico», Vall d’Hebron Institut de Recerca, Hospital Universitari Vall d’Hebron, Barcelona, Spain; Corresponding author.Unidad de Patología Infecciosa e Inmunodeficiencias de Pediatría, Hospital Universitari Vall d’Hebron, Barcelona, Spain; Grupo de investigación «Infección e inmunidad en el paciente pediátrico», Vall d’Hebron Institut de Recerca, Hospital Universitari Vall d’Hebron, Barcelona, Spain; Departamento de Pediatría, Obstetricia y Ginecología y de Medicina Preventiva y Salud Pública, Universitat Autònoma de Barcelona, Barcelona, SpainSección Enfermedades Infecciosas Pediátricas, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Área de Enfermedades Infecciosas Pediátricas, Centro de Investigación Biomédica en Red del Instituto de Salud Carlos III (CIBERINFEC), Madrid, Spain; Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Hospital General Universitario Gregorio Marañón, Madrid, SpainFebrile neutropenia is one of the main infectious complications experienced by paediatric patients with blood or solid tumours, which, despite the advances in diagnosis and treatment, are still associated with a significant morbidity and mortality. These patients have several risk factors for infection, chief of which are chemotherapy-induced neutropenia, the disruption of cutaneous and mucosal barriers and the use of intravascular devices. Early diagnosis and treatment of febrile neutropenia episodes based on the patient’s characteristics is essential in patients with blood and solid tumours to improve their outcomes. Therefore, it is important to develop protocols in order to optimise and standardise its management. In addition, the rational use of antibiotics, with careful adjustment of the duration of treatment and antimicrobial spectrum, is crucial to address the increase in antimicrobial drug resistance.The aim of this document, developed jointly by the Spanish Society of Pediatric Infectious Diseases and the Spanish Society of Pediatric Hematology and Oncology, is to provide consensus recommendations for the management of febrile neutropenia in paediatric oncology and haematology patients, including the initial evaluation, the stepwise approach to its treatment, supportive care and invasive fungal infection, which each facility then needs to adapt to the characteristics of its patients and local epidemiological trends. Resumen: La neutropenia febril es una de las principales complicaciones infecciosas que sufren los pacientes pediátricos oncohematológicos, y a pesar los avances en diagnóstico y tratamiento, siguen condicionando una mortalidad y morbilidad significativa. Estos pacientes agrupan una serie de factores de riesgo de infección, donde destaca la neutropenia asociada a quimioterapia, la disrupción de barreras cutáneo-mucosas y el uso de dispositivos intravasculares. El abordaje diagnóstico y terapéutico precoz de los episodios de neutropenia febril en los pacientes oncohematológicos, ajustado a las características individuales de cada paciente, es fundamental para mejorar su pronóstico. Por ello, diseñar protocolos de abordaje, que sistematicen su atención, permite optimizar y homogeneizar su abordaje. Además, racionalizar el uso de los antimicrobianos, ajustando la duración y el espectro de los mismos, es crucial para hacer frente al incremento de resistencias a antimicrobianos.El objetivo de este documento, elaborado entre la Sociedad Española de Infectología Pediátrica y la Sociedad Española de Hematología y Oncología Pediátrica, es dar recomendaciones de consenso sobre el manejo de la neutropenia febril en el paciente oncohematológico, respecto al abordaje inicial, terapia secuencial y de soporte e infección fúngica invasiva, que cada centro debe adaptar a las características de sus pacientes y epidemiología local.http://www.sciencedirect.com/science/article/pii/S2341287923001114Neutropenia febril inducida por quimioterapiaNeoplasiasPediatríaInfección fúngica invasivaAntibióticosAntifúngicos
spellingShingle Leticia Martínez Campos
Paula Pérez-Albert
Laia Ferres Ramis
Elena María Rincón-López
Natalia Mendoza-Palomar
Pere Soler-Palacin
David Aguilera-Alonso
Consensus document on the management of febrile neutropenia in paediatric haematology and oncology patients of the Spanish Society of Pediatric Infectious Diseases (SEIP) and the Spanish Society of Pediatric Hematology and Oncology (SEHOP)
Anales de Pediatría (English Edition)
Neutropenia febril inducida por quimioterapia
Neoplasias
Pediatría
Infección fúngica invasiva
Antibióticos
Antifúngicos
title Consensus document on the management of febrile neutropenia in paediatric haematology and oncology patients of the Spanish Society of Pediatric Infectious Diseases (SEIP) and the Spanish Society of Pediatric Hematology and Oncology (SEHOP)
title_full Consensus document on the management of febrile neutropenia in paediatric haematology and oncology patients of the Spanish Society of Pediatric Infectious Diseases (SEIP) and the Spanish Society of Pediatric Hematology and Oncology (SEHOP)
title_fullStr Consensus document on the management of febrile neutropenia in paediatric haematology and oncology patients of the Spanish Society of Pediatric Infectious Diseases (SEIP) and the Spanish Society of Pediatric Hematology and Oncology (SEHOP)
title_full_unstemmed Consensus document on the management of febrile neutropenia in paediatric haematology and oncology patients of the Spanish Society of Pediatric Infectious Diseases (SEIP) and the Spanish Society of Pediatric Hematology and Oncology (SEHOP)
title_short Consensus document on the management of febrile neutropenia in paediatric haematology and oncology patients of the Spanish Society of Pediatric Infectious Diseases (SEIP) and the Spanish Society of Pediatric Hematology and Oncology (SEHOP)
title_sort consensus document on the management of febrile neutropenia in paediatric haematology and oncology patients of the spanish society of pediatric infectious diseases seip and the spanish society of pediatric hematology and oncology sehop
topic Neutropenia febril inducida por quimioterapia
Neoplasias
Pediatría
Infección fúngica invasiva
Antibióticos
Antifúngicos
url http://www.sciencedirect.com/science/article/pii/S2341287923001114
work_keys_str_mv AT leticiamartinezcampos consensusdocumentonthemanagementoffebrileneutropeniainpaediatrichaematologyandoncologypatientsofthespanishsocietyofpediatricinfectiousdiseasesseipandthespanishsocietyofpediatrichematologyandoncologysehop
AT paulaperezalbert consensusdocumentonthemanagementoffebrileneutropeniainpaediatrichaematologyandoncologypatientsofthespanishsocietyofpediatricinfectiousdiseasesseipandthespanishsocietyofpediatrichematologyandoncologysehop
AT laiaferresramis consensusdocumentonthemanagementoffebrileneutropeniainpaediatrichaematologyandoncologypatientsofthespanishsocietyofpediatricinfectiousdiseasesseipandthespanishsocietyofpediatrichematologyandoncologysehop
AT elenamariarinconlopez consensusdocumentonthemanagementoffebrileneutropeniainpaediatrichaematologyandoncologypatientsofthespanishsocietyofpediatricinfectiousdiseasesseipandthespanishsocietyofpediatrichematologyandoncologysehop
AT nataliamendozapalomar consensusdocumentonthemanagementoffebrileneutropeniainpaediatrichaematologyandoncologypatientsofthespanishsocietyofpediatricinfectiousdiseasesseipandthespanishsocietyofpediatrichematologyandoncologysehop
AT peresolerpalacin consensusdocumentonthemanagementoffebrileneutropeniainpaediatrichaematologyandoncologypatientsofthespanishsocietyofpediatricinfectiousdiseasesseipandthespanishsocietyofpediatrichematologyandoncologysehop
AT davidaguileraalonso consensusdocumentonthemanagementoffebrileneutropeniainpaediatrichaematologyandoncologypatientsofthespanishsocietyofpediatricinfectiousdiseasesseipandthespanishsocietyofpediatrichematologyandoncologysehop